Maternal Interleukin-6 Is Associated With Macaque Offspring Amygdala Development and Behavior
Overview
Authors
Affiliations
Human and animal cross-sectional studies have shown that maternal levels of the inflammatory cytokine interleukin-6 (IL-6) may compromise brain phenotypes assessed at single time points. However, how maternal IL-6 associates with the trajectory of brain development remains unclear. We investigated whether maternal IL-6 levels during pregnancy relate to offspring amygdala volume development and anxiety-like behavior in Japanese macaques. Magnetic resonance imaging (MRI) was administered to 39 Japanese macaque offspring (Female: 18), providing at least one or more time points at 4, 11, 21, and 36 months of age with a behavioral assessment at 11 months of age. Increased maternal third trimester plasma IL-6 levels were associated with offspring's smaller left amygdala volume at 4 months, but with more rapid amygdala growth from 4 to 36 months. Maternal IL-6 predicted offspring anxiety-like behavior at 11 months, which was mediated by reduced amygdala volumes in the model's intercept (i.e., 4 months). The results increase our understanding of the role of maternal inflammation in the development of neurobehavioral disorders by detailing the associations of a commonly examined inflammatory indicator, IL-6, on amygdala volume growth over time, and anxiety-like behavior.
Adipokines measured during pregnancy and at birth are associated with infant negative affect.
Sullivan E, Molloy K, Dunn G, Balanzar A, Young A, Loftis J Brain Behav Immun. 2024; 120:34-43.
PMID: 38772428 PMC: 11401062. DOI: 10.1016/j.bbi.2024.05.018.
Segmenting hypothalamic subunits in human newborn magnetic resonance imaging data.
Rasmussen J, Wang Y, Graham A, Fair D, Posner J, OConnor T Hum Brain Mapp. 2024; 45(2):e26582.
PMID: 38339904 PMC: 10826633. DOI: 10.1002/hbm.26582.
Depression, anxiety, insomnia and interleukins in the early postpartum period.
Drozdowicz-Jastrzebska E, Mach A, Skalski M, Januszko P, Jabiry-Zieniewicz Z, Siwek M Front Psychiatry. 2023; 14:1266390.
PMID: 37840785 PMC: 10569220. DOI: 10.3389/fpsyt.2023.1266390.
Neudecker V, Perez-Zoghbi J, Miranda-Dominguez O, Schenning K, Ramirez J, Mitchell A Br J Anaesth. 2023; 131(6):1030-1042.
PMID: 37714750 PMC: 10687619. DOI: 10.1016/j.bja.2023.07.031.
Comorbidity of Anxiety and Hypertension: Common Risk Factors and Potential Mechanisms.
Qiu T, Jiang Z, Chen X, Dai Y, Zhao H Int J Hypertens. 2023; 2023:9619388.
PMID: 37273529 PMC: 10234733. DOI: 10.1155/2023/9619388.